Prof. Pei is a cell biologist. He received his Ph.D. from the University of North Carolina in 1991, before proceeding his postdoctoral research at Duke University from 1992 to February 1995, and was elected as an Academician of Chinese Academy of Sciences in 1999. Prof. Pei once served as Director of Shanghai Institutes for Biological Sciences of Chinese Academy of Sciences and President of Tongji University.
Prof. Zhong is an expert on respiratory diseases and an Advanced Personage in the fight against SARS in 2003. He once served as President of Chinese Medical Association, Director of Guangzhou Institute of Respiratory Diseases, Vice President of Guangdong Association of Science and Technology, etc. Prof. Zhong was inducted in the first batch of national experts with outstanding contributions, and appointed as Directorial Member of Chinese Thoracic Society of Chinese Medical Association, Medical Advisor for Smoking & Health to WHO at UN, and Special Member of International Thoracic Society and Director of its Asia-Pacific Executive Committee.
Prof. Hou is Director of Nephrology Department of Nanfang Hospital, Academician of The World Academy of Sciences (TWAS), Director of National Clinical Research Center for Kidney Diseases, Director of National Key Laboratory of Organ Failure Research, Director of International Society of Nephrology (ISN), and Vice Directorial Member of Chinese Society of Nephrology. Prof. Hou graduated from Sun Yat-sen Medical University (now School of Medicine of Sun Yat-sen University) in 1993 with a doctorate in medicine. She worked in Harvard Medical School from June 1995 to December 1998, and has served as Director of Institute of Nephrology of People's Liberation Army (now Institute of Nephrology of Southern Medical University), a professor of internal medicine at The First Military Medical University (now Southern Medical University), Director of Nephrology Department of Nanfang Hospital, and a doctoral tutor since 1999.
Prof. Xu is a cell biophysicist and a professor at University of Chinese Academy of Sciences. Prof. Xu graduated from Huazhong University of Science and Technology in 1992 and received his doctorate in medicine in 1997. He once served as Director of Institute of Biophysics of Chinese Academy of Sciences and was elected as Member of Chinese Academy of Sciences in 2017. Prof. Xu is now the Director of GRMH-GDL, also the Vice President of University of Chinese Academy of Sciences.
Prof. Chen is a cell biophysicist and a professor at Tsinghua University. He graduated from Department of Biology of Jiangxi University in 1983, obtained a master's degree there in 1986 and another master's degree from Fordham University in 1990, and received a doctorate from Albert Einstein College of Medicine in 1996. Prof. Chen was elected as an academician of Chinese Academy of Sciences in 2017, and is now Chairman of Chinese Society for Cell Biology.
Prof. Wang is a biomaterials science and engineering expert. She graduated from South China University of Technology in 1978, and received her master's and doctoral degrees there in 1981 and 1997 respectively. Prof. Wang was invited as an adjunct professor at Himeji Institute of Technology from January to July 1993, and was a senior visiting fellow at University of Florida from October 1998 to March 1999. She was former president of South China University of Technology, and is now Director of National Research Center for Engineering Technology of Human Functional Tissue Reconstruction, discipline leader of inorganic non-metallic materials, and Vice President of Guangdong Association of Science and Technology.
Prof. Su is a neuroanatomist, a part-time professor of Faculty of Medicine of University of Hong Kong, Honorary Director of State Key Laboratory of Brain and Cognitive Science (University of Hong Kong), Co-Chair of Board of Directors of China Spinal Cord Injury Network. Prof. Su graduated from Massachusetts Institute of Technology in 1977 with a doctorate. He was awarded the State Natural Science Award in 1995, elected as an academician of Chinese Academy of Sciences in 1999, and appointed as an academic inventor of National Institute of Inventors in 2015.
Prof. Song obtained his M.D. and Ph.D. from Sun Yat-sen University, and trained as physician at Sun Yat-sen Memorial Hospital, SYSU. He had postdoc training at Essen University Hospital in Germany and Harvard Medical School from 1999 to 2004. His early publication “RNA interference targeting Fas protects mice from fulminant hepatitis” in Nature Medicine was the first to report that siRNA could be used therapeutically in whole animal disease model, and selected as one of the “Ten breakthroughs of the year 2003” by Science. After setting up his lab at Sun Yat-sen University in China, he has focused his research on the microenvironment of malignant tumors, mainly on breast cancers, and unraveled the regulatory mechanisms of non-coding RNAs (ncRNAs) related to tumor microenvironment. 2007, Prof. Song was elected as Cheung Kong Scholars Programme Distinguished Professor. Prof. Song was nominated as the president of Sun Yat-Sen Memorial Hospital in 2016, and servers as dean of Zhongshan School of Medicine from 2017.
Professor Horace H. Loh is a pharmacologist. He received his Ph.D. in biochemistry from the University of Iowa in 1965. He was a faculty member at the University of California, San Francisco Medical Center (UCSF) until 1988. He became the Head of the Department of Pharmacology at the University of Minnesota in 1989. Dr. Loh served in this capacity and also as the Frederick and Alice Stark Professor in Neuroscience until 2012. Dr. Loh was recognized by the University of Minnesota as a Regents Professor in 2010. Currently he is the Honorary Director at General Pain Institute.